$36.8M
$9,000
0.0% of portfolio
8,910
Q2 2025
Reduced 21.1%
$261M
$379,000
0.0% of portfolio
215,715
Q2 2025
Added 15.1%
$2.39B
$1.11 Million
0.0% of portfolio
199,240
Q2 2025
Added 33.75%
$50M
$0
0.0% of portfolio
547
Q2 2025
Added 147.51%
$1.75B
$13.1 Million
0.0% of portfolio
468,236
Q2 2025
Added 0.37%
-
$0
0.0% of portfolio
-
Q2 2025
New
$443M
$48,000
0.0% of portfolio
8,972
Q2 2025
Added 0.1%
$230M
$1.21 Million
0.0% of portfolio
153,078
Q2 2025
Reduced 25.63%
$31.7M
$0
0.0% of portfolio
139
Q2 2025
Added 15.83%
$49M
$14,000
0.0% of portfolio
2,095
Q2 2025
Added 0.38%
$219M
$96,000
0.0% of portfolio
28,492
Q2 2025
Reduced 1.25%
$26.3M
$0
0.0% of portfolio
1,040
Q2 2025
Reduced 94.68%
$1.03B
$23.1 Million
0.0% of portfolio
8,756,183
Q2 2025
Added 1,522.59%
$1.6B
$6.06 Million
0.0% of portfolio
193,200
Q2 2025
Reduced 34.6%
-
$0
0.0% of portfolio
-
Q2 2025
Added 11.76%
$114M
$926,000
0.0% of portfolio
99,676
Q2 2025
Reduced 71.06%
$48.4M
$2,000
0.0% of portfolio
2,010
Q2 2025
Added 0.5%
$3.55B
$11.6 Million
0.0% of portfolio
421,726
Q2 2025
Reduced 10.64%
$142M
$14,000
0.0% of portfolio
8,887
Q2 2025
Added 300.32%
-
$0
0.0% of portfolio
-
Q2 2025
Added 370.59%
$4.92B
$17.7 Million
0.0% of portfolio
159,592
Q2 2025
Added 180.91%
-
$0
0.0% of portfolio
-
Q2 2025
Added 234.68%
-
$0
0.0% of portfolio
-
Q2 2025
New
$74.6M
$15,000
0.0% of portfolio
823
Q2 2025
Added 0.12%
Indaptus Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
$3.89B
$38.5 Million
0.0% of portfolio
2,176,859
Q2 2025
Added 3.16%
$3.16B
$24.8 Million
0.0% of portfolio
394,392
Q2 2025
Added 13.56%
$678M
$2.11 Million
0.0% of portfolio
65,059
Q2 2025
Added 6.02%
$0
$529,000
0.0% of portfolio
32,045
Q2 2025
Reduced 14.29%
$476M
$2.21 Million
0.0% of portfolio
622,160
Q2 2025
Added 139.51%
-
$0
0.0% of portfolio
-
Q2 2025
Added 24.62%
$410M
$118,000
0.0% of portfolio
26,017
Q2 2025
Reduced 57.57%
-
$0
0.0% of portfolio
-
Q2 2025
Added 303.32%
$249M
$628,000
0.0% of portfolio
131,031
Q2 2025
Reduced 3.65%
$213M
$112,000
0.0% of portfolio
17,994
Q2 2025
Added 19.4%
$2.17B
$12 Million
0.0% of portfolio
278,212
Q2 2025
Added 16.46%
$977M
$3.84 Million
0.0% of portfolio
60,631
Q2 2025
Reduced 4.1%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 23.53%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 57.32%
-
$0
0.0% of portfolio
-
Q2 2025
Added 19.18%
$1.25B
$12.5 Million
0.0% of portfolio
862,209
Q2 2025
Added 142.14%
$32.1M
$28,000
0.0% of portfolio
12,173
Q2 2025
Reduced 59.95%
-
$0
0.0% of portfolio
-
Q2 2025
Added 315.63%
$1.62B
$2.64 Million
0.0% of portfolio
51,496
Q2 2025
Reduced 68.84%
$2.06B
$24.8 Million
0.0% of portfolio
295,498
Q2 2025
Added 21.26%
$563M
$57,000
0.0% of portfolio
15,535
Q2 2025
Added 8.58%
-
$0
0.0% of portfolio
-
Q2 2025
Added 0.46%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 97.47%
$1.58B
$728,000
0.0% of portfolio
13,194
Q2 2025
Added 41.16%
$195M
$18,000
0.0% of portfolio
1,321
Q2 2025
Reduced 97.43%